HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Zhang Selected Research

Exanthema (Rash)

1/2021Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study.
1/2021Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancer.
1/2021Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer.
1/2020Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial.
1/2020Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
1/2019Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.
11/2018Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer.
1/2018First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance.
1/2018Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung.
1/2017Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Zhang Research Topics

Disease

1269Neoplasms (Cancer)
12/2022 - 03/2002
310Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 10/2003
308Inflammation (Inflammations)
12/2022 - 10/2002
235Infections
12/2022 - 08/2003
205Neoplasm Metastasis (Metastasis)
10/2022 - 03/2002
126Lung Neoplasms (Lung Cancer)
04/2022 - 06/2002
123Breast Neoplasms (Breast Cancer)
01/2022 - 08/2004
110Stroke (Strokes)
06/2022 - 04/2002
105Carcinogenesis
08/2022 - 08/2002
103Hypoxia (Hypoxemia)
01/2022 - 03/2002
97Hepatocellular Carcinoma (Hepatoma)
07/2022 - 01/2001
92Ischemia
08/2022 - 04/2002
91Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2005
89Fibrosis (Cirrhosis)
08/2022 - 08/2002
85Body Weight (Weight, Body)
02/2022 - 01/2003
80Stomach Neoplasms (Stomach Cancer)
12/2022 - 03/2005
72Carcinoma (Carcinomatosis)
01/2022 - 06/2002
71Pain (Aches)
05/2022 - 07/2007
68Nasopharyngeal Carcinoma
01/2022 - 08/2002
65Disease Progression
01/2022 - 08/2005
63COVID-19
12/2022 - 01/2020
63Hypertension (High Blood Pressure)
05/2022 - 10/2003
62Adenocarcinoma of Lung
06/2022 - 04/2007
61Wounds and Injuries (Trauma)
09/2022 - 03/2004
61Glioma (Gliomas)
04/2022 - 02/2005
61Infarction (Infarctions)
03/2022 - 02/2002
59Parkinson Disease (Parkinson's Disease)
07/2022 - 02/2004
57Insulin Resistance
04/2022 - 05/2004
55Necrosis
06/2022 - 01/2003
53Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 10/2004
53Reperfusion Injury
01/2022 - 04/2003
52Myocardial Infarction
04/2022 - 05/2003
52Sepsis (Septicemia)
02/2022 - 06/2004
50Non-alcoholic Fatty Liver Disease
09/2022 - 05/2011
49Type 2 Diabetes Mellitus (MODY)
08/2022 - 09/2004
49Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 04/2005
48Obesity
03/2022 - 09/2004
47Pneumonia (Pneumonitis)
05/2022 - 02/2010
47Brain Ischemia (Cerebral Ischemia)
01/2022 - 04/2002
44Alzheimer Disease (Alzheimer's Disease)
12/2022 - 11/2010
44Leukemia
01/2022 - 07/2004
42Hemorrhage
07/2022 - 04/2003
42Atherosclerosis
04/2022 - 11/2002
40Adenocarcinoma
12/2022 - 06/2002
40Glioblastoma (Glioblastoma Multiforme)
03/2022 - 03/2005
40Melanoma (Melanoma, Malignant)
02/2022 - 12/2003
39Lymphatic Metastasis
01/2022 - 07/2006
38Ischemic Stroke
01/2022 - 08/2004
37Embolic Stroke
01/2021 - 04/2002
36Cognitive Dysfunction
09/2022 - 04/2011
36Asthma (Bronchial Asthma)
08/2022 - 01/2010

Drug/Important Bio-Agent (IBA)

469Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2002
240Pharmaceutical PreparationsIBA
09/2022 - 11/2002
239Biomarkers (Surrogate Marker)IBA
09/2022 - 04/2005
149MicroRNAs (MicroRNA)IBA
08/2022 - 10/2010
142CytokinesIBA
08/2022 - 01/2003
138Messenger RNA (mRNA)IBA
06/2022 - 04/2002
128Biological ProductsIBA
08/2022 - 01/2004
113ErbB Receptors (EGF Receptor)IBA
01/2022 - 11/2002
104Glucose (Dextrose)FDA LinkGeneric
08/2022 - 09/2004
102LipidsIBA
09/2022 - 08/2004
88Immune Checkpoint InhibitorsIBA
10/2022 - 06/2015
86Long Noncoding RNAIBA
06/2022 - 05/2014
85DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2002
85EnzymesIBA
05/2022 - 01/2003
80Therapeutic UsesIBA
05/2022 - 02/2004
77RNA (Ribonucleic Acid)IBA
11/2022 - 05/2009
75Tyrosine Kinase InhibitorsIBA
10/2022 - 05/2004
74Peptides (Polypeptides)IBA
08/2022 - 05/2004
65Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 04/2002
64LigandsIBA
12/2022 - 12/2002
64Gefitinib (Iressa)FDA Link
07/2022 - 05/2004
64Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2004
60VaccinesIBA
12/2022 - 05/2004
60LipopolysaccharidesIBA
10/2022 - 01/2003
58Indicators and Reagents (Reagents)IBA
08/2022 - 10/2004
58Interleukin-6 (Interleukin 6)IBA
02/2022 - 01/2003
57Phosphotransferases (Kinase)IBA
08/2022 - 07/2004
55Neuroprotective AgentsIBA
01/2022 - 07/2003
53AntigensIBA
06/2022 - 07/2003
53Insulin (Novolin)FDA Link
04/2022 - 05/2004
51Small Interfering RNA (siRNA)IBA
04/2022 - 01/2006
51Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 - 12/2004
49AntibodiesIBA
10/2022 - 03/2004
49AntioxidantsIBA
05/2022 - 06/2003
47Transcription Factors (Transcription Factor)IBA
05/2022 - 10/2004
44CholesterolIBA
04/2022 - 11/2002
43CollagenIBA
09/2022 - 04/2005
42Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 01/2003
42Oxygen (Dioxygen)IBA
12/2021 - 09/2004
40CateninsIBA
09/2022 - 01/2010
37Monoclonal AntibodiesIBA
12/2022 - 03/2004
37Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 06/2005

Therapy/Procedure

722Therapeutics
12/2022 - 02/2003
294Drug Therapy (Chemotherapy)
09/2022 - 12/2002
103Immunotherapy
06/2022 - 02/2004
101Radiotherapy
10/2022 - 08/2002
66Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2022 - 11/2003
49Lasers (Laser)
07/2022 - 06/2002
49Aftercare (After-Treatment)
05/2022 - 04/2002